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Abstract We have constructed a fusion protein, T-ZZ, in which
the IgG-Fc binding protein ZZ was fused to the C-terminus of
the diphtheria toxin transmembrane domain (T domain). While
soluble at neutral pH, T-ZZ retained the capacity of the T
domain to bind to phospholipid membranes at acidic pH. Once
anchored to the membrane, the ZZ part of the protein was
capable of binding mouse monoclonal or rabbit polyclonal IgG.
Our results show that the T-ZZ protein can function as a pH
sensitive membrane anchor for the linkage of IgG to the
membrane of lipid vesicles, adherent and non-adherent cells.
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1. Introduction
Attachment of antibodies to natural or synthetic mem-
branes may have application in basic science, biotechnology,
biosensor technology, diagnostics and biotherapeutics. In the
past 15 years the linkage of antibodies to membranes has been
developed, mostly for the design of cell-targeted immunolipo-
somes. The linkage is generally performed by chemical cou-
pling either to a derivatized phospholipid initially incorpo-
rated into the membrane or to an acylated chain which will
further be incorporated into the lipid bilayer, often with the
help of detergents. Recently, it was shown that acylation of a
recombinant scFv can also be performed biosynthetically, but
its insertion into membranes still requires the use of detergents
[1]. The drawback is that detergents must be removed through
time consuming steps, and are not compatible with some ap-
plications. Moreover, they may not be used for the linkage of
antibodies to the membrane of living cells.
Our objective was to design a membrane anchor which
would allow for the attachment of antibodies to synthetic or
natural phospholipid bilayers as well, without the need for
detergents or chemical cross linking reagents which interfere
with membranes or cell surface proteins. Anchoring should be
fast and triggered when desired by a simple mechanism.
The diphtheria toxin transmembrane domain (T domain)
has the remarkable property of being water soluble at neutral
pH, whereas it inserts into membranes at acidic pH [2^6]. In
the whole toxin, this property enables the T domain to assist
the translocation of the catalytic domain from the acidic en-
docytic compartment to the cytoplasm, during the intoxica-
tion of a cell [2,3,7^9]. We have studied whether the T domain
could be used as a membrane anchor for the antibody binding
protein ZZ. ZZ was generated by duplication of a mutated B
domain from the staphylococcal protein A [10] and was
shown to bind to the Fc region of IgG [11]. Here we describe
a T-ZZ fusion protein and its use as a membrane anchor for
mouse and rabbit IgG.
2. Materials and methods
2.1. Bacterial strains, antibodies and cell culture reagents
Escherichia coli strain NovaBlue (Novagen, Madison, WI, USA)
was used for plasmid propagation and cloning, and strain
BL21(DE3) (Novagen) was used as the host for fusion protein pro-
duction. Polyclonal horse anti-diphtheria toxin antibody was obtained
from MeŁrieux (Marcy-l’Etoile, France), rabbit anti-horse IgG-, goat
anti-mouse IgG- and goat anti-rabbit IgG-F(abP)2-peroxidase conju-
gates were purchased from Immunotech (Marseilles, France) and
FITC-labeled mouse IgG2a from Sigma. Cell culture media were
from Biological Industries (Kibbutz Beit Haemek, Israel).
2.2. Construction of vector pCD2-ZZ
The pET11d derived parental plasmid pETJV127 [12] encoding the
diphtheria toxin-interleukin-2 fusion toxin DAB389-IL-2 was digested
with NcoI to introduce a DNA fragment made by hybridization of the
following oligonucleotides: 5P-CATGGGTCATCACCATCACCAT-
CACGATGACGATGACAAATG-3P and 5P-CATGCATTTGTCAT-
CGTCATCGTGATGGTGATGGTGATGACC-3P. As a result, the
N-terminal methionine of the encoded DAB389-IL-2 protein is pre-
ceded by the following sequence: Met-Gly-His-His-His-His-His-His-
Asp-Asp-Asp-Asp-Lys-Cys, and an NsiI restriction site encompasses
the Cys codon. The resulting plasmid pCD1 was digested with NsiI to
remove the region coding the diphtheria toxin catalytic domain, lead-
ing to plasmid pCD2-hIL-2. pCD2-hIL-2 was digested with SphI and
HindIII to remove the IL-2 coding region at the 3P end of the se-
quence coding for the T domain. The coding sequence for ZZ [10,11]
was PCR ampli¢ed from plasmid pCP [13] using primers designed to
introduce an SphI and a HindIII restriction site at the 5P and 3P ends
of the fragment, respectively: 5P-CCACGGACCCGCATGCTGCG-
CAACACGATGAAGCCGT-3P and 5P- CCGGTATGCCAAGCTT-
TTACTAAGAATTCGCGTCTACTTTCGGC-3P. After digestion
with SphI and HindIII, the ZZ ampli¢ed sequence was ligated in
plasmid pCD2-hIL-2 to give plasmid pCD2-ZZ.
2.3. Expression and puri¢cation of the fusion protein T-ZZ
Protein expression was done at 37‡C in Terri¢c Broth (12 g/l tryp-
tone, 24 g/l yeast extract (Difco, Detroit, MI, USA), 0.4% glycerol (v/
v), 17 mM KH2PO4, 72 mM K2HPO4) supplemented with 0.2 mg/l
ampicillin from BL21(DE3) cells transfected with plasmid pCD2-ZZ.
Induction was started at OD600 = 0.6 by the addition of 0.1 mM IPTG
(Fluka, Buchs, Switzerland) and carried on for 2 h. Cells were har-
vested by centrifugation and resuspended in 20 ml of 50 mM Tris-HCl
pH 8, 10 mM EDTA, 8% sucrose (w/v), 5% Triton X-100 (v/v) sup-
plemented with 0.1 ml of 0.1 M PMSF (Sigma) in ethanol and 1 ml of
a 10 mg/ml solution of lysozyme (Sigma). After 1 h incubation on ice,
the cells were lysed by sonication for 5 min (power setting 50%, pulse
1 s, rest 1 s) and the soluble cytoplasmic fraction containing T-ZZ was
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recovered by centrifugation at 14 000Ug for 30 min at 4‡C and
treated with 1 Wg/ml of DNAse and RNAse for 1 h at 20‡C.
Puri¢cation was done by a⁄nity chromatography on an IgG Sepha-
rose 6 Fast Flow column according to the manufacturer’s protocol
(Pharmacia, Uppsala, Sweden). The pH of the eluted protein sample
was immediately brought back from 3.4 to 7.4 with 2 M Tris-HCl pH
9. Because the activity of the T domain was a¡ected by the rather
strong acidic pH of the elution bu¡er, the protein was treated with
6 M guanidine hydrochloride and 1 mM DTT and refolded by dialysis
against 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5% glycerol and
stored at 320‡C.
Some aggregation of T-ZZ could be observed by quasi elastic light
scattering. This problem was eliminated by keeping the protein at a
concentration below 0.5 mg/ml in the presence of 5% glycerol. Few
remaining aggregates were removed by centrifugation 20 min at 14 000
rpm.
2.4. Liposome perforation assay
Large unilamellar vesicles (LUV) were prepared by reverse phase
evaporation as described [14] using a mixture of egg phosphatidylcho-
line and egg phosphatidic acid (Avanti Polar Lipids, Alabaster, AL,
USA) at a molar ratio of 9/1. The bu¡er used for preparation was 25
mM KH2PO4, 50 mM K2SO4, 50 mM Na2SO4, 25 mM MES pH 7.2
supplemented with 0.2 mM pyranine (Molecular Probes, Eugene, OR,
USA). The preparation was extruded through 0.4 and 0.2 Wm poly-
carbonate ¢lters (Millipore, Bedford, MA, USA) to obtain LUV of a
uniform size distribution of about 120 nm. The ¢nal phospholipid
concentration was about 16 mg/ml (20 mM). LUV were separated
from non-entrapped pyranine by size exclusion chromatography on
a G50 sephadex column.
50 Wl of LUV suspension was added to 950 Wl of the bu¡er used for
the vesicle preparation in a quartz cuvette in a spectro£uorimeter LS
50 (Perkin-Elmer) under constant magnetic stirring at 37‡C. Excita-
tion was performed at 460 nm and emission was recorded at 510 nm.
In a typical experiment of 200 s, the following reagents were added
sequentially: at t = 0 s, 2 Wl of 0.1 mM valinomycin (Sigma) in etha-
nol; at t = 15 s, 38 Wl of 1 M H2SO4 ; at t = 40 s, protein samples; at
t = 140 s, 2 Wl of 0.1 mM carbonyl cyanide p-(tri£uoromethoxy) phen-
ylhydrazone (FCCP) (Sigma) in ethanol; at t = 180 s, 38 Wl of 1 M
KOH. When present, the pyranine quencher DPX (Molecular Probes)
was added before starting recording at a ¢nal concentration of 20
mM. Diphtheria toxin (Sigma) used as a control was nicked with
trypsin [15] and reduced with 20 mM DTT. The amounts of proteins
used were 12 Wg for T-ZZ (3U1037 M) and 10 Wg for diphtheria toxin
(1037 M) to get maximum e¡ect. Preincubation of the proteins with
antibodies was done by mixing an excess of puri¢ed antibodies with
the protein sample 5 min before adjunction to the quartz cuvette.
2.5. Liposome £oatation experiments
The method was adapted from [16]. LUV containing pyranine were
prepared as described above. 0.8 mg of LUV were incubated at 20‡C
with 20 Wg of T-ZZ in 350 Wl of 20 mM Tris, 150 mM NaCl pH 7.4 and
pH was dropped to 5 or maintained at 7.4 by the adjunction of 50 Wl of
250 mM MES at pH 3.4 or 7.4. At this step, concentrations were 2.5
mM for lipids and 1.3U1036 M for T-ZZ. After incubation overnight,
samples were then mixed to a 60% sucrose, 20 mM Tris, 150 mM NaCl
solution to reach 40% sucrose. A 40%, 30%, 20%, 10% and 5% dis-
continuous sucrose gradient was made for each sample in a 8 ml Beck-
man polycarbonate ultracentrifuge tube. Gradients were centrifuged
for 1 h at 110 000Ug in a ¢xed angle rotor. The top 5% sucrose
fraction containing the LUV visible by their turbidity, and the bottom
40% sucrose fraction were harvested. The presence of pyranine was
analyzed by £uorescence detection (excitation at 465 nm and emission
at 530 nm) after dilution 1/4 in 1 M Tris pH 8, 0.1% SDS. The presence
of proteins was analyzed by SDS-PAGE, electrotransfer onto a nylon
membrane and Western detection using anti-diphtheria toxin antibod-
ies and an anti-antibody-peroxidase conjugate.
2.6. Liposome enzyme linked immuno¢ltration assay (lipo-ELIFA)
Small unilamellar vesicles (SUV) were prepared by sonication of a
dispersion of 50 mg egg phosphatidylcholine and 5 mg egg phospha-
tidic acid in 3 ml of PBS pH 7.4 (Sigma) for 5 min. The ¢nal phos-
pholipid concentration of the preparation was 18.3 mg/ml (22.9 mM).
The assay was performed on 96 well Multiscreen-HA 0.45 Wm mixed
esters of cellulose ¢lter plates (Millipore). At each step, 200 Wl/well of
each solution was applied to the plate and vacuum-¢ltered using a
Millipore MultiScreen device. All dilutions and washes were done
with PBS pH 7.4 unless otherwise stated. SUV diluted 1/8 were ¢rst
adsorbed on the ¢lters. Filters were then saturated with PBS contain-
ing 0.3% BSA (Sigma) (w/v) and washed once. Ten Wg of T-ZZ
(2.5U1037 M) was added in PBS at pH 7.4 or at pH 5 followed by
a wash. Filters were saturated again with BSA and washed three
times. Mouse monoclonal IgG2a or rabbit serum diluted 1/1000 in
PBS supplemented with 0.1% BSA were added, plates were washed
three times, goat anti-mouse IgG- or goat anti-rabbit IgG-F(abP)2-
peroxidase conjugate at a 1/5000 dilution in PBS supplemented with
0.1% BSA were added, and plates were washed three times. 25 Wl of
ABTS substrate solution (Pierce, Rockford, Il, USA) prepared ac-
cording to the manufacturer’s instructions was added, the ¢ltrates
were harvested in a 96 well ELISA plate placed inside the Millipore
MultiScreen device, and wells were rinsed with 200 Wl of PBS to
ensure good recovery of the substrate transformed by the peroxidase.
The ELISA plate was read in a Titertek Multiscan MCC 340 spec-
trophotometer at 414 nm.
2.7. Cell surface binding immunodetection assay
105 adherent ¢broblastic mouse L cells per well were seeded on 96
well plates (Nunc) in Dulbecco-MEM supplemented with 10% fetal
calf serum and 2 mM glutamine and grown overnight to con£uence.
Cells were washed three times with PBS at pH 7.4. T-ZZ was diluted
in PBS at pH 5 or at pH 7.4, from 5 Wg to 0.04 Wg per 50 Wl
(2.6U1036 M to 2U1038 M). 50 Wl per well of each dilution was
incubated with the cells at 20‡C for 15 min. The cells were washed
three times with PBS at pH 7.4. 100 Wl of mouse monoclonal IgG2a or
rabbit serum at a 1/1000 dilution in PBS supplemented with 0.1%
BSA was added to the cells at 4‡C for 1 h. After three washes with
PBS, the cells were incubated with 100 Wl of the corresponding goat
anti-mouse IgG- or goat anti-rabbit IgG-F(abP)2-peroxidase conjugate
at a 1/5000 dilution in PBS supplemented with 0.1% BSA at 4‡C for
1 h. After three washes with PBS, plates were developed with 200 Wl of
ABTS (Pierce) according to the manufacturer’s instructions and ab-
sorbency at 414 nm was read in a Titertek 340nm spectrophotometer.
Viability of cells treated with the highest concentration of T-ZZ as
above was assayed with the £uorescent metabolic marker AlamarBlue
(Biosource International) according to the manufacturer’s instruc-
tions.
For FACS studies on the non-adherent cell line FDC-P1, the pro-
tocol was similar. 2.5 Wg of T-ZZ in 50 Wl (1.2U1036 M) were in-
cubated with 2.5U105 cells 15 min at 20‡C. The presence of T-ZZ was
detected using a FITC-labeled mouse IgG2a at a 1/30 dilution. Cells
were washed by centrifugation in conical bottom 96 well minisorp
plates (Nunc).
3. Results
3.1. Construction, expression and puri¢cation of the T-ZZ
fusion protein
The construction of the plasmid pCD2-ZZ for the expres-
sion of the fusion protein T-ZZ is described in the materials
and methods section. T-ZZ contains successively: Met-Gly, a
six His tag, an enterokinase cleavage site, the T domain from
Cys-201 to Thr-386 (numbering from native diphtheria toxin),
His-Ala corresponding to the SphI restriction site, Ala-Gln-
His-Asp-Glu-Ala, two Z sequences [10,11], and ¢nally Val-
Asp-Ala-Asn-Ser.
T-ZZ was expressed in E. coli and about 9 mg of protein
was puri¢ed from 1 l of bacterial culture. Coomassie blue
staining of the fusion protein following SDS-PAGE shows
that it has been puri¢ed nearly to homogeneity (Fig. 1). Its
apparent molecular mass is consistent with the value deduced
from its amino acid sequence (38.6 kDa).
3.2. pH sensitive interaction of T-ZZ with the membrane
of vesicles
The pH sensitive interaction of T-ZZ with membranes was
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¢rst monitored by measurements of the permeabilization of
LUV to small molecules. Fig. 2A shows that the pH sensitive
£uorescent probe pyranine, entrapped into LUV, was pro-
tected from H added to the medium when pH was brought
down from 7.4 to 5. The adjunction of FCCP, a ionophore
carrying H across the membranes, provoked extinction of
pyranine £uorescence due to its titration by H. A similar
drop of £uorescence was observed when T-ZZ or diphtheria
toxin were added to the vesicles after acidi¢cation (Fig. 2A),
showing permeabilization of the LUV. Compare to diphtheria
toxin on a molar basis, 3-fold more T-ZZ were necessary to
obtain a maximum e¡ect. Fig. 2B shows that when the same
experiment was done in the presence of DPX, a quencher of
pyranine, £uorescence was not recovered after returning the
pH to 7.4 at the end of the experiment. This demonstrated
mixing of pyranine and DPX after contact with T-ZZ at pH 5.
Thus, at acidic pH, T-ZZ permeabilized LUV not only to H,
but also to small organic compounds. T-ZZ did not perforate
LUV at pH 7.4 as DPX did not quench pyranine £uorescence
in these conditions (Fig. 2B). Similar observations were made
with diphtheria toxin (not shown).
Interestingly, preincubation of T-ZZ with an excess of anti-
diphtheria toxin antibodies, but not mouse monoclonal IgG
or rabbit polyclonal antibodies, prevented membrane perme-
abilization (Fig. 2C). Antibodies alone had no e¡ect on mem-
brane permeability in the same conditions of acidic pH (Fig.
2D).
Taken together, these results show that T-ZZ is able to
interact with membranes at acidic pH by its T domain. Anti-
bodies bound to ZZ do not prevent this interaction.
3.3. pH dependent permeabilization of LUV by T-ZZ
correlates with binding of the protein to the vesicles
T-ZZ was incubated with LUV containing pyranine, at pH
7.4 or 5. The samples were then incorporated in the high
concentration sucrose fraction (40%) of discontinuous sucrose
gradients. The gradients were ultracentrifuged in order to al-
low the LUV to £oat up to the low concentration sucrose
fraction (5%) at the top of the gradients where they were
visually detectable by their turbidity. Fig. 3A shows that pyr-
anine remained associated with the LUV when incubations
were done at pH 7.4. At acidic pH, pyranine remained in
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Fig. 1. SDS-PAGE analysis of 2 Wg of puri¢ed T-ZZ by Coomassie
blue staining.
Fig. 2. Permeabilization of LUV by T-ZZ at acidic pH monitored
by the pH sensitive £uorescent probe pyranine entrapped inside the
LUV. A: Comparison of the e¡ects of T-ZZ and diphtheria toxin
(DT). B: Comparison of the e¡ect of T-ZZ at pH 7.4 or 5, in the
presence or absence of the pyranine quencher DPX. C: Comparison
of the e¡ects of T-ZZ alone or preincubated with horse anti-diph-
theria toxin antibodies (anti DT), or mouse or rabbit non speci¢c
antibodies. D: E¡ect of the antibodies in the absence of T-ZZ.
Fig. 3. Floatation of LUV containing pyranine in discontinuous sucrose gradients, following incubation with T-ZZ at neutral or acidic pH.
LUV loaded in the 40% sucrose fraction of each gradient were found in the 5% sucrose fraction after centrifugation. A: Partition ratios of pyr-
anine in the 40% and 5% sucrose fractions of each gradient. No £uorescence was detected in intermediary sucrose fractions. B: Partition ratios
of T-ZZ in the 40% and 5% sucrose fractions of each gradient analyzed by SDS-PAGE and Western detection (C) and calculated from the den-
sitometry measurements of the bands on the Western blot in C.
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the 40% sucrose fraction, indicating leakage out of the LUV.
This con¢rmed the data from the perforation assay. Leakage
of pyranine was not observed at either pH in the absence of
T-ZZ.
Fig. 3B,C shows that at pH 5, about 2/3 of the molecules of
T-ZZ migrated from the 40% sucrose fraction to the 5% su-
crose fraction of the gradient during centrifugation, together
with the LUV. The explanation is that these molecules were
bound to the LUV. This was not the case at pH 7.4 at which
almost all the molecules remained in the 40% sucrose fraction.
Altogether these results show that T-ZZ associates with the
membrane of LUV at acidic pH and that membrane perme-
abilization is most likely a consequence of this association.
3.4. Binding of IgG to T-ZZ anchored to the surface of vesicles
We have studied the capacity of IgG to bind to T-ZZ anch-
ored to the membrane of SUV by lipo-ELIFA. SUV were
adsorbed onto ¢lters and put in contact with T-ZZ at pH
7.4 or 5, by ¢ltration. Mouse monoclonal IgG2a or rabbit
serum were then incubated by ¢ltration and the presence of
IgG was revealed with a goat anti-mouse IgG- or a goat anti-
rabbit IgG-F(abP)2-peroxidase conjugate. Fig. 4 shows that
IgG were retained at the surface of the SUV when the SUV
were incubated ¢rst with T-ZZ at acidic pH. If incubation of
T-ZZ was done at neutral pH, IgG bound to the vesicles at a
much lower extent. Binding was negligible in the absence of T-
ZZ. Incorporation of a £uorescent labeled phospholipid
(NBD-phosphatidyl ethanolamine) in the SUV allowed to
check that the amount of vesicles was the same on each ¢lter
at each step of the experiment whatever the experimental con-
ditions (not shown).
3.5. Binding of IgG to the surface of cells treated with T-ZZ
Adherent ¢broblastic L cells grown to con£uence were in-
cubated with varying amounts of T-ZZ at pH 5 or pH 7.4.
After washing, mouse monoclonal IgG2a or rabbit serum
were incubated with the cells and the presence of IgG was
detected with a goat anti-mouse IgG- or a goat anti-rabbit
IgG-F(abP)2-peroxidase conjugate (Fig. 5A,B). The results
show that IgG attached to cells preincubated with T-ZZ at
pH 5 but not at pH 7.4, in a dose dependent manner with
respect to T-ZZ. Similar results were obtained with the adher-
ent breast carcinoma cell line SKBR3 (not shown). Interest-
ingly, viability of the cells was not a¡ected by the treatment
(Fig. 5C).
Similar experiments were done on the non-adherent cell line
FDC-P1. The cells were incubated with T-ZZ at neutral or
acidic pH. The cells were washed, incubated with an FITC
labeled mouse IgG2a, and washed again. The presence or
absence of the antibody at the surface of the cells was ana-
lyzed by FACS (Fig. 6). Most of the cells were clearly labeled
when T-ZZ was incubated at acidic pH (Fig. 6B). In contrast,
labeling was very weak when T-ZZ was incubated at pH 7.4
(Fig. 6A). Binding of the mouse IgG2a could be inhibited if
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Fig. 4. Binding of a mouse monoclonal IgG2a (A) or rabbit poly-
clonal IgG (B) to SUV immobilized on ¢lters and treated with or
without T-ZZ at neutral or acidic pH. Measures were done in dupli-
cate.
Fig. 5. Binding of a mouse monoclonal IgG2a (A) or rabbit poly-
clonal IgG (B) to the surface of adherent L cells treated with vary-
ing amounts of T-ZZ at neutral or acidic pH. C: E¡ect of treat-
ment on cell viability. All measures were done in duplicate.
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once treated with T-ZZ at pH 5, the cells were ¢rst incubated
with rabbit serum (Fig. 6B). Preincubation of T-ZZ with anti-
diphtheria toxin antibodies also prevented labeling (Fig. 6D).
Labeling was not signi¢cantly reduced when rabbit serum or
anti-diphtheria toxin antibodies were added after incubation
with the FITC labeled mouse IgG2a (Fig. 6F).
These results indicate that T-ZZ attaches to adherent and
non-adherent cells at acidic pH by its T domain, and then
may bind IgG by its ZZ domain.
4. Discussion
In this work, we have shown that a fusion protein made of
the T domain of diphtheria toxin and the IgG-Fc binding
protein ZZ combines the properties of both fusion partners
and may function as a pH sensitive membrane anchor for
IgG. Once bound to the surface of vesicles or cells by the T
domain, the ZZ domain of T-ZZ retains its capacity to bind
IgG from mouse, rabbit (this study), or hamster (not shown).
If IgG are allowed to bind to soluble T-ZZ in the ¢rst place, T
is still capable of interacting with the membrane of vesicles.
Although we did not study this situation in detail, we suppose
that it is also possible to anchor T-ZZ/IgG complexes to
membranes. Indeed, interaction of IgG with ZZ is stable at
pH 5 and is disrupted only below pH 3.5.
Previous reports have described the insertion into mem-
branes of the T domain, isolated [4^6] or in the whole toxin
[17^23]. Some of these studies have shown a relation between
insertion and permeabilization to small molecules [5,17,18].
Our data are consistent with these reports and suggest that
the T domain of T-ZZ penetrates into arti¢cial lipid bilayers.
The interaction of the T domain with the cell surface seems to
be di¡erent. Cell viability is not a¡ected by the binding of the
protein which remains detectable on the cell surface for at
least 4 h (not shown). This suggests that the cell membranes
are not permeabilized and questions whether or not the T
domain penetrates the lipid bilayer. Indeed, two types of in-
teractions with cell membranes have been described for diph-
theria toxin [24]. When the toxin is ¢rst allowed to bind to its
receptor it inserts into the membrane leading to the formation
of a channel [24^26]. In the absence of receptor, as this is the
case in our study, cells are not permeabilized and the inter-
action is super¢cial [24]. Thus, di¡erent types of interactions
with membranes may be observed for the T domain depend-
ing on the complexity and on the composition of the mem-
branes [6].
The most interesting feature of T-ZZ is the moderate drop
of pH needed for triggering its binding to the membrane. This
is well tolerated by many synthetic membrane systems and
living cells. Membrane attachment is rapid. Vesicle permea-
bilization occurs within seconds at protein concentrations
around 5U1037 M. If proteins are added before the pH
drop (not shown), the kinetic of insertion is even faster, sug-
gesting that the rate limiting step in the process is the di¡usion
of the protein leading to membrane encounter. The kinetic of
binding to cells is also fast, most of the e¡ect occurring within
minutes (not shown).
One drawback might be discussed. The modi¢cation of
membrane permeability is a problem if one wants to use the
system for cell receptor targeting of vesicles containing small
compounds. Whether the lipid composition of the membrane
might in£uence this phenomenon must be investigated. Any-
way, the development of new lipid vehicles such as multila-
mellar vesicles or vesosomes (a few vesicles entrapped in a
larger one) [27] may solve this problem.
Various applications of our system may be found including
the targeting of vesicles to cell receptors or the tagging of cells
for identi¢cation or separation. More broadly, we propose to
use the T domain as a membrane anchor for any water solu-
ble protein fused at its C-terminus. In another work (submit-
ted) we have anchored cytokines to the membrane of vesicles
and cells by this mean.
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